After two years of thoughtful analysis, Einstein has reorganized its basic-science departments. The changes, which took effect in January 2022, were made to improve Einstein’s position as a leading research-intensive medical school.
Based on their research interests, faculty from two departments—physiology & biophysics and anatomy and structural biology—were shifted to other departments: biochemistry, cell biology, developmental and molecular biology, genetics, microbiology & immunology, molecular pharmacology, neuroscience, and pathology.
The changes were instituted in part to allow Einstein to better unify scientific efforts that were previously dispersed across departments, promote collaboration, and help integrate research programs with Montefiore. The reorganization is expected to stimulate the exchange of ideas, enhance mentorship opportunities, and streamline administrative operations.
Gordon Tomaselli, M.D., the Marilyn and Stanley M. Katz Dean at Einstein and vice president and chief academic officer at Montefiore, offered his “heartfelt thanks” to former chairs Denis Rousseau, Ph.D. (physiology & biophysics), and John Condeelis, Ph.D., and Robert Singer, Ph.D. (anatomy and structural biology), for their decades of leadership.